Michael Keith currently serves as the Global Health Economics and Outcomes Research (HEOR) Lead at Rocket Pharmaceuticals, a position held since July 2023. Prior to this, Michael served as Medical Director for Oncology Strategy at Gilead Sciences from January 2021 to July 2023 and held multiple senior roles focusing on health economics and market access at Sage Therapeutics and Alcon, a division of Novartis, among others. Michael’s extensive experience includes leadership in health economics at Shire Pharmaceuticals and Kinetic Concepts, where strategic management and development of health outcomes functions were key responsibilities. Michael holds a PhD and PharmD in Health Economics and Outcomes Research from The University of Texas at Austin, completed in 2002.
This person is not in any teams
This person is not in any offices